Evolution in thinking and processes?

Drug Discovery Today: Technologies

Volumn 5, Issue 1, 2008, Pages

  Sewing, Andreas ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATORIAL CHEMISTRY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; REVIEW;

EID: 68249098697     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2008.12.002     Document Type: Review

References (35)

1. Booth B., and Zemmel R. Prospects for productivity. Nat. Rev. Drug Discov. 3 (2004) 451-455
2. Hamilton M., et al. Financial anatomy of biomedical research. JAMA 294 (2005) 1333-1342
3. Schmid E.F., and Smith D.A. Is declining innovation in the pharmaceutical industry a myth?. DDT 10 (2005) 1031-1039
4. Pisano G.P. Can science be a business?. Harv. Bus. Rev. (2006). HBR.ORG
5. Handen J.S. The industrialisation of drug discovery. DDT 7 (2002) 83-85
6. Witty, A. (2008) In Cash-Rich Drugmakers Eye Mergers or Aquisitions, Weintraub A, Business Week http://biz.yahoo.com/bizwk/081120/0845b4107044224586.html?.v=1
7. Caldwell G.W., et al. The new pre-preclinical paradigm: compound optimisation in early and late phase drug discovery. Curr. Top. Med. Chem. 1 (2001) 353-366
8. Di L., and Kerns E.H. Profiling dug-like properties in discovery research. Curr. Opin. Chem. Biol. 7 (2003) 402-408
9. Schmid E.F., and Smith D.A. Should scientific innovation be managed?. DDT 7 (2002) 941-945
10. Ullman F., and Boutellier R. A case study of lean drug discovery: from project driven research to innovation studios and process factories. DDT 13 (2008) 543-549
11. Weller H.N., et al. Application of lean manufacturing concepts to drug discovery: rapid analogue library synthesis. J. Comb. Chem. 8 (2008) 664-669
12. Hammond C., and O'Donnell C.J. Lean six sigma - its application to drug discovery. Drug Discov. World Spring (2008) 9-19
13. Jagschies G. Operational excellence - the future of biopharmaceutical manufacturing. Inn. Pharm. Technol. (2008) 57-60
14. Sewing A., et al. Helping science to succeed: improving processes in R&D. DDT 13 (2008) 227-233
15. Petrillo E.W., et al. Lean thinking for drug discovery - better productivity for pharma. Drug Discov. World Spring (2007) 9-14
16. Schmid E.F., and Smith D.A. R&D technology investments: misguided and expensive or a better way to discover medicines. DDT 11 (2006) 775-784
17. Houston J.G., et al. Case study: impact of technology investment on lead discovery at Bristol Myers Squibb, 1998-2006. DDT 13 (2008) 44-50
18. Amir-Aslani A., and Negassi S. Is technology integration the solution to biotechnology's low research and development productivity?. Technovation 26 (2006) 573-582
19. Golebiowski A., et al. Lead compounds discovered from libraries. Curr. Opin. Chem. Biol. 5 (2001) 273-284
20. Golebiowski A., et al. Lead compounds discovered from libraries: Part 2. Curr. Opin. Chem. Biol. 7 (2003) 308-325
21. Lane S.J. Defining and maintaining a high quality screening collection. DDT 11 (2006) 267-272
22. Bender A., et al. Which aspects of HTS are empirically correlated with downstream success?. Curr. Opin. Drug Discov. Dev. 11 (2008) 327-337
23. Fox S. High throughput screening: update on practices and processes. J. Biomol. Screen. 11 (2006) 864-869
24. Gribbon P., and Sewing A. High throughput discovery: what can we expect from HTS. DDT 10 (2005) 17-22
25. Landers P. Human element: drug industry's big push into technology falls short. Wall Street J. (2004). http://www.wsj.com
26. Keserü G.M., and Makara G.M. Hit discovery and hit to lead approaches. DDT 11 (2006) 741-747
27. Kunapuli P., et al. Application of division arrest technology to cell-based HTS: comparison with frozen and fresh cells. Assay Drug Dev. Technol. 3 (2005) 17-26
28. Katso R.M., et al. J. Biomol. Screen. 10 (2005) 715-724
29. Wang D.Y., et al. Development of a high throughput cell-based assay for 11beta-hydroxysteroid dehydrogenase type 1 using BacMam technology. Mol. Biotechnol. 39 (2008) 127-134
30. Clark D.E. Outsourcing lead optimisation: constant change is here to stay. DDT 12 (2007) 6270
31. Hirano, H. (1995) 5 Pillars of the Visual Workplace, Productivity Press, ISBN 1-56327-123-0
32. Ullman F. Physical layout of workspace: a driver for productivity in drug discovery. DDT 13 (2008) 374-378
33. Tom McCarty. Six Sigma at Motorola www.motorola.com/motorolauniversity
34. Kaizen, M.I. (1986) The Key to Japan's Competitive Success, McGraw-Hill/Irwin, ISBN 0-07-554332-X
35. Cuatrecasas P. Drug discovery in jeopardy. J. Clin. Invest. 116 (2006) 2837-2842